Navigation Links
Avantium Appoints Jonathan Wolfson to its Supervisory Board
Date:1/31/2013

AMSTERDAM, January 31, 2013 /PRNewswire/ --

Avantium announced the appointment of Jonathan Wolfson to its Supervisory Board. Jonathan Wolfson is Chief Executive Officer and co-founder of Solazyme. Solazyme is a leading industrial biotechnology company producing renewable oil and bioproducts from microalgae for fuels, chemicals, nutrition and personal care products. Solazyme (SZYM) is a US stock listed company at NASDAQ. Mr. Wolfson and Solazyme have received numerous awards for their technology pioneering role in the industrial biotechnology industry. Mr. Wolfson holds J.D. and M.B.A. degrees from the NYU School of Law and the NYU Stern School of Business

Jonathan Wolfson said on his appointment:"I am very happy to join the Supervisory Board at Avantium.  I have known the Company for years and have been increasingly impressed with its world class catalytic technology and the incredibly exciting development of the YXY technology platform.  I look forward to working with the company as it brings its disruptive biobased plastics and chemicals to market."

"We are proud to have Jonathan Wolfson appointed to our Supervisory Board", says Tom van Aken , CEO of Avantium. "Jonathan has played a major role in the successful development of Solazyme, its successful IPO and the formation of strategic partnerships in the food, cosmetics and fuels industries. His experience and insights in bringing biobased chemicals to the market, will be very valuable for Avantium to commercialize its YXY technology for the production and use of FDCA and PEF."

About Avantium

Avantium is a game-changing renewable chemicals company with leadership in advanced catalysis R&D. It developed the breakthrough YXY technology, a proprietary process to convert carbohydrates into the green building blocks FDCA for making biobased plastics and biobased chemicals at cost competitive prices in large markets. Avantium's lead application PEF (polyethylene furanoate) fulfils key criteria to become the next generation biobased plastics for bottles, film and fibers. Avantium has demonstrated the value and commercial potential of its unique technology by collaborating with leading companies like The Coca-Cola Company and Danone for the development of 100% biobased PEF bottles. Avantium plans to have the first commercial scale manufacturing plant operational by 2016. Avantium laboratories and headquarters are based in Amsterdam, the Netherlands.


'/>"/>
SOURCE Avantium
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
4. Hybrid Fuels, Inc. Appoints Industry Expert as New CEO
5. BioStorage Technologies Appoints New Member to Board of Directors
6. Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development
7. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
8. PuraMed BioScience, Inc. Appoints Sue A. Baacke, CPA, as CFO
9. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
10. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
11. Veracyte Appoints Mark Spring as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... Francisco, CA (PRWEB) , ... February 04, 2016 ... ... of enterprise talent development and compliance training, today announced an interactive FDA ... Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on ...
(Date:2/4/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... Edward Lanphier , Sangamo,s president and chief executive ... Sangamo,s ZFP Therapeutic ® development programs and an ... ET on Thursday, February 11, 2016, at the Leerink ... conference is being held in New York ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Forensics Club, takes place February 5-6 at the University’s student center, Kehr ... activities such as workshops and competitions for ample networking, learning and collaborating ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 Technology ... service presents an analysis of the digital and computed ... Malaysia , and Indonesia ... current trends and market size, as well as regional ... by country and discusses market penetration and market attractiveness, ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
Breaking Biology News(10 mins):